Open AccessMycophenolate Mofetil as an Effective Corticosteroid-Sparing Therapy for Recalcitrant Dermatomyositis
Author(s) -
Johnathon C Edge,
J. David Outland,
Jennifer R Dempsey,
Jeffrey P. Callen
Publication year - 2006
Publication title -
archives of dermatology
Language(s) - English
Resource type - Journals
eISSN - 1538-3652
pISSN - 0003-987X
DOI - 10.1001/archderm.142.1.65
Subject(s) - medicine , mycophenolate , adverse effect , dermatomyositis , corticosteroid , mycophenolic acid , dermatology , urinary system , concomitant , surgery , gastroenterology , transplantation
Dermatomyositis (DM) is a multisystem idiopathic inflammatory disorder that most commonly affects the muscles and skin. Systemic corticosteroids are the mainstay of therapy but are limited by their long-term adverse effects.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom